Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of candidate DNA methylation biomarkers related to Alzheimer's disease risk by integrating genome and blood methylome data. | Transl Psychiatry | 2023 | 38092781 | PubTator, text mining | PubMed |
| Serous Cystadenoma: A Review on Diagnosis and Management. | J Clin Med | 2023 | 38068358 | PubTator, text mining | PubMed |
| RNF43 mutation as a predictor of immunotherapeutic efficacy in colorectal cancer. | Am J Cancer Res | 2023 | 38058823 | PubTator, text mining | PubMed |
| TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma. | J Transl Med | 2023 | 38037073 | PubTator, text mining | PubMed |
| The fusion gene hsf5-rnf43 in Nile tilapia: A potential regulator in the maintenance of testis function and sexual differentiation. | iScience | 2023 | 38026183 | PubTator, text mining | PubMed |
| Emerging trends in clinical cancer genomic research. | Cancer Biol Med | 2023 | 38018030 | PubTator, text mining | PubMed |
| IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins. | Molecules | 2023 | 38005242 | PubTator, text mining | PubMed |
| Intestinal Paneth cell differentiation relies on asymmetric regulation of Wnt signaling by Daam1/2. | Sci Adv | 2023 | 38000028 | PubTator, text mining | PubMed |
| LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer. | Cells | 2023 | 37998393 | PubTator, text mining | PubMed |
| Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer. | Curr Pharmacol Rep | 2023 | 37994344 | PubTator, text mining | PubMed |
| Role of Exosomal Non-Coding RNA in the Tumour Microenvironment of Genitourinary System Tumours. | Technol Cancer Res Treat | 2023 | 37981789 | PubTator, text mining | PubMed |
| High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma. | Hum Pathol | 2023 | 37977512 | PubTator, text mining | PubMed |
| Genetic insights: High germline variant rate in an indigenous African cohort with early-onset colorectal cancer. | Front Oncol | 2023 | 37965459 | PubTator, text mining | PubMed |
| BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature. | Cancers (Basel) | 2023 | 37958416 | PubTator, text mining | PubMed |
| Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. | JCO Precis Oncol | 2023 | 37944072 | PubTator, text mining | PubMed |
| Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications. | Front Immunol | 2023 | 37942325 | PubTator, text mining | PubMed |
| Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations. | Biomed Pharmacother | 2023 | 37939617 | PubTator, text mining | PubMed |
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. | Front Immunol | 2023 | 37928532 | PubTator, text mining | PubMed |
| Tumor vaccines: Toward multidimensional anti-tumor therapies. | Hum Vaccin Immunother | 2023 | 37905395 | PubTator, text mining | PubMed |
| Intraductal papillary neoplasm of the bile duct: The new frontier of biliary pathology. | World J Gastroenterol | 2023 | 37900587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=11